title: Oral presentation of minocycline-induced black bone disease.
abstract: Minocycline hydrochloride is a semisynthetic tetracycline derivative used widely for the treatment of acne vulgaris. Among its side effects is the ability to pigment many tissues particularly thyroid, skin, tooth, and bone. A case is presented in which long-term minocycline therapy (500 g taken orally over 11 years) resulted in dark bone pigmentation (black bone disease) severe enough to be visible through the alveolar and palatal mucosa. No skin or tooth pigmentation was present.
authors.affiliation: Department of Oral Medicine and Pathology, UMDS, Guy's Hospital, London, United Kingdom.
authors.forename: E W
authors.initials: EW
authors.lastname: Odell
authors.forename: R P
authors.initials: RP
authors.lastname: Hodgson
authors.forename: R
authors.initials: R
authors.lastname: Haskell
mesh_terms: D000152:Acne Vulgaris / Q000188:drug therapy; D000328:Adult; D000539:Alveolar Process / Q000187:drug effects*; D005260:Female; D006801:Humans; D017495:Hyperpigmentation / Q000139:chemically induced*; D008911:Minocycline / Q000009:adverse effects*
chemical_list: D008911:Minocycline